Sanofi agrees to acquire DynaVax for $2.2 bln, adds hepatitis B vaccine
MLex Summary: Paris-based Sanofi agreed to acquire Emeryville, California-based Dynavax Technologies for a total equity value of about $2.2 billion. The deal is expected to close the first quarter of 2026....To view the full article, register now.
Already a subscriber? Click here to view full article